Osmotica Pharmaceuticals PLC Announces Definitive Agreement with Alora Pharmaceuticals LLC Transcript
Good morning, ladies and gentlemen, and welcome to the Osmotica Strategic Sales Call. (Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to turn the conference over to your first speaker today, Ms. Judy DiClemente. Thank you. Please go ahead.
Thank you, Stacy. Welcome to Osmotica Pharmaceuticals call regarding the sale of its legacy business to Alora Pharmaceuticals, LLC. This is Judy DiClemente, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andrew Einhorn. This morning, the company issued a press release for the sale of its legacy business to Alora Pharmaceuticals, LLC. This press release and a webcast of this call can be accessed through the Investors Section of the Osmotica website at osmotica.com.
Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |